[Therapeutic drug monitoring in psychiatry. A brief summary of the new consensus paper by the task force on TDM of the AGNP]

G Gründer; P Baumann; A Conca; G Zernig; C Hiemke; TDM-Gruppe der AGNP

doi:10.1007/s00115-013-3925-2

[Therapeutic drug monitoring in psychiatry. A brief summary of the new consensus paper by the task force on TDM of the AGNP]

Nervenarzt. 2014 Jul;85(7):847-55. doi: 10.1007/s00115-013-3925-2.

[Article in German]

Authors

G Gründer¹, P Baumann, A Conca, G Zernig, C Hiemke; TDM-Gruppe der AGNP

Affiliation

¹ Klinik für Psychiatrie, Psychotherapie und Psychosomatik, RWTH Aachen, Pauwelsstr. 30, 52074, Aachen, Deutschland, ggruender@ukaachen.de.

PMID: 24346428
DOI: 10.1007/s00115-013-3925-2

Abstract

In October 2011 the Task Force Therapeutic Drug Monitoring of the Association for Neuropsychopharmacology and Pharmacopsychiatry (AGNP) published an update (Pharmacopsychiatry 2011, 44: 195-235) of the first version of the consensus paper on therapeutic drug monitoring (TDM) published in 2004. This article summarizes the essential statements to make them accessible to a wider readership in German speaking countries.

Publication types

English Abstract
Review

MeSH terms

Drug Monitoring / standards*
Germany
Humans
Pharmacogenetics / standards*
Practice Guidelines as Topic*
Psychopharmacology / standards*
Psychotropic Drugs / therapeutic use*

Substances

Psychotropic Drugs